Novartis AG
Time frame: 1 May 2023 - 30 April 2024Article ‘Count’ and ‘Share’ for Novartis AG based on listed parameters only.
The articles listed below published by authors from Novartis AG, organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
American Journal of Respiratory and Critical Care Medicine |
2 | 0.51 |
Annals of the Rheumatic Diseases |
1 | 0.72 |
Blood |
1 | 0.23 |
Circulation |
2 | 0.68 |
Clinical Infectious Diseases |
1 | 0.04 |
European Heart Journal |
1 | 0.18 |
Gastroenterology |
1 | 0.11 |
Hepatology |
1 | 0.27 |
Journal of Clinical Oncology |
2 | 0.57 |
Journal of the American College of Cardiology |
8 | 1.79 |
Kidney International |
1 | 0.44 |
Nature |
3 | 1.00 |
Nature Communications |
10 | 4.04 |
Nature Medicine |
3 | 0.00 |
Ophthalmology |
3 | 0.03 |
Proceedings of the National Academy of Sciences of the United States of America |
1 | 0.03 |
Science Advances |
1 | 0.06 |
The Journal of Allergy and Clinical Immunology |
2 | 0.47 |
The Lancet |
1 | 0.25 |
The Lancet Global Health |
1 | 0.11 |
The Lancet Neurology |
1 | 0.06 |
The Lancet Oncology |
1 | 0.15 |
The New England Journal of Medicine |
5 | 1.19 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.